Sequenom snatches up prenatal testing intellectual property; German team spots new thyroid cancer biomarker;

> Sequenom ($SQNM) paid close to $14.6 million for intellectual property from Isis Innovation involving noninvasive prenatal testing. Story (reg. req.)

> Biocept ($BIOC) is expanding its ovarian cancer diagnostics collaboration with MD Anderson Cancer Center. Release

> GE ($GE) named John Flannery as president and CEO of GE Healthcare; Flannery used to be the SVP of business development at the company. Story

> German scientists have identified a new biomarker that points to a cause of thyroid cancer. Item

> Massachusetts Institute of Technology and Tufts University researchers developed a new assay that generates its own synthetic biomarkers to help spot harmful blood clots in mice. Story